Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease

F Tang, B Sally, K Lesko, V Discepolo… - Journal of Experimental …, 2015 - rupress.org
F Tang, B Sally, K Lesko, V Discepolo, V Abadie, C Ciszewski, C Semrad, S Guandalini
Journal of Experimental Medicine, 2015rupress.org
Eicosanoids are inflammatory mediators that play a key but incompletely understood role in
linking the innate and adaptive immune systems. Here, we show that cytotoxic effector T
cells (CTLs) are capable of both producing and responding to cysteinyl leukotrienes
(CystLTs), allowing for the killing of target cells in a T cell receptor–independent manner.
This process is dependent on the natural killer receptor NKG2D and exposure to IL-15, a
cytokine induced in distressed tissues. IL-15 and NKG2D signaling drives the up-regulation …
Eicosanoids are inflammatory mediators that play a key but incompletely understood role in linking the innate and adaptive immune systems. Here, we show that cytotoxic effector T cells (CTLs) are capable of both producing and responding to cysteinyl leukotrienes (CystLTs), allowing for the killing of target cells in a T cell receptor–independent manner. This process is dependent on the natural killer receptor NKG2D and exposure to IL-15, a cytokine induced in distressed tissues. IL-15 and NKG2D signaling drives the up-regulation of key enzymes implicated in the synthesis of CystLTs, as well as the expression of CystLT receptors, suggesting a positive feedback loop. Finally, although the CystLT pathway has been previously linked to various allergic disorders, we provide unexpected evidence for its involvement in the pathogenesis of celiac disease (CD), a T helper 1 cell–mediated enteropathy induced by gluten. These findings provide new insights into the cytolytic signaling pathway of NKG2D and the pathogenesis of organ-specific immune disorders. Furthermore, they suggest that the blockade of CystLT receptors may represent a potent therapeutic target for CD or potentially other autoimmune disorders in which NKG2D has been implicated.
rupress.org